A Harvard scientist’s experimental cancer treatment, based on messenger RNA technology, was expected to start clinical trials next year. However, the sudden announcement from Health Secretary Robert F. Kennedy Jr. that federal funding will no longer be provided for this type of vaccine has sent shockwaves through the scientific community and pharmaceutical industries.
Moderna, a leading biotech company, as well as other biotechs developing mRNA treatments for various diseases, are heavily impacted by the decision. The mRNA technology that underpins COVID-19 vaccines is now being cut off from federal funding, leaving its future uncertain.
Source: https://www.bostonglobe.com/2025/08/15/business/rfk-moderna-mrna-vaccines-medicine